BTBD9 rs3923809: What Your Genotype Means
The rs3923809 variant is a genetic marker located within the BTBD9 gene. It is widely recognized in scientific literature for its statistical association with an increased susceptibility to restless legs syndrome (RLS) and periodic limb movements during sleep.
What each genotype means
Increased restless legs risk
This genotype is associated with a higher statistical likelihood of developing restless legs syndrome (RLS) and periodic limb movements during sleep (PLMS). Research suggests this variant may influence iron homeostasis, which is a factor in these sleep-related conditions. Please note that this is a complex trait influenced by many genetic and environmental factors, and this result does not constitute a medical diagnosis.
Carried by a significant portion of the population, with the A allele being common in European ancestries.
Slightly increased risk profile
Individuals with this genotype show a slightly increased statistical association with restless legs syndrome compared to those without the A allele. The biological mechanism is thought to involve the BTBD9 gene's role in iron regulation, though the exact pathway remains a subject of ongoing research. This association is based on population-level data and does not predict individual health outcomes.
This heterozygous genotype is frequently observed in populations where the A allele is prevalent.
Baseline risk profile
This genotype is considered the baseline or normal risk profile for this specific genetic variant in the context of restless legs syndrome susceptibility. It does not carry the specific genetic association linked to increased risk observed with the A allele. As with all genetic findings, this should be viewed as one small piece of a much larger health picture.
The G allele is common, with frequencies reaching approximately 70% in European populations and 50% in East Asian populations.
Understanding the rs3923809 Variant
The rs3923809 variant is a single nucleotide polymorphism (SNP) situated within the BTBD9 gene on chromosome 6. In genetics, a SNP represents a variation at a single position in the DNA sequence. This specific variant is located in an intronic region, meaning it resides in a non-coding part of the gene that does not directly provide instructions for building a protein. However, intronic variants can still influence how genes are regulated or expressed. Researchers use this SNP as a marker to study the genetic architecture of complex traits. Because it is located in a region that may affect gene function, it has become a focal point for understanding the biological pathways that contribute to sleep-related disorders. It is important to note that while this variant is statistically associated with certain traits, it is only one of many factors—both genetic and environmental—that influence human health.
The Role of the BTBD9 Gene
The BTBD9 gene provides instructions for creating a protein that belongs to the BTB/POZ domain-containing family. While the exact function of the BTBD9 protein in humans remains a subject of ongoing research, studies in model organisms, such as fruit flies and mice, suggest it plays a role in neurological processes. Specifically, the protein has been linked to the regulation of dopamine, a neurotransmitter essential for movement and reward, and the maintenance of iron homeostasis in the brain. Iron is a critical cofactor for enzymes involved in dopamine synthesis. When iron levels are dysregulated, it can impair the dopaminergic system, which is a known factor in the pathophysiology of restless legs syndrome. By studying the BTBD9 gene, scientists hope to better understand how these molecular mechanisms influence sleep quality and motor control during rest.
Research and Evidence Strength
The association between rs3923809 and restless legs syndrome (RLS) was identified through genome-wide association studies (GWAS). These studies compare the DNA of individuals with a specific condition to those without it to find common genetic markers. The evidence for this association is considered robust in terms of statistical correlation, with some studies suggesting it may account for a significant portion of the population risk for RLS. However, the evidence is categorized as limited regarding its direct clinical utility for individual diagnosis. While the link to periodic limb movements during sleep (PLMS) and altered serum ferritin levels is well-documented in research, the biological pathway from the variant to the clinical symptoms is complex and not fully understood. Consequently, this variant is used primarily in research settings to explore the genetic basis of sleep disorders rather than as a definitive diagnostic tool for clinical practice.
Interpreting Your Results
If you have information about your rs3923809 genotype, it is important to view it within the context of your overall health. Genetic associations are statistical probabilities, not medical diagnoses. Many people with the risk-associated genotype never develop restless legs syndrome, and many people without it do. If you are experiencing symptoms such as uncomfortable sensations in your legs at rest or sleep disturbances, you should consult a healthcare professional. They can evaluate your symptoms, check your iron levels, and discuss appropriate management strategies. Never use genetic information to make decisions about medication or treatment without professional guidance. If a clinician prescribes medication for RLS, such as dopamine agonists or other agents, always discuss dosing and potential side effects with them or your pharmacist. Genetic data is a tool for understanding your biological predispositions, but it should never replace a comprehensive clinical evaluation by a qualified medical provider.
How common is this variant?
The G allele is quite common, with a frequency of approximately 70% in European populations and about 50% in East Asian populations.
Frequently asked questions
Does having the rs3923809 risk allele mean I will get RLS?
No. Genetic associations indicate an increased statistical probability, not a certainty. Many factors, including iron levels and other genetic or environmental influences, determine whether someone develops restless legs syndrome.
Can I use this test to diagnose restless legs syndrome?
No. RLS is a clinical diagnosis made by a doctor based on your symptoms and medical history. Genetic testing for this variant is not a standard diagnostic tool.
What should I do if I have the risk genotype and symptoms?
You should schedule an appointment with your primary care physician or a sleep specialist. They can perform a physical exam, check your blood iron levels, and discuss evidence-based treatment options.
Is there a cure for the genetic risk associated with BTBD9?
There is no way to change your genetic code. However, symptoms associated with RLS are often manageable through lifestyle changes, iron supplementation if a deficiency is confirmed, or medications prescribed by a doctor.
Sources & further reading
Educational information only, last refreshed 10/16/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs3923809?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in BTBD9
This variant in the BTBD9 gene is strongly associated with susceptibility to restless legs syndrome (RLS).
A prominent non-coding variant in BTBD9 strongly conferring risk for periodic limb movements during sleep and restless legs syndrome.
Genome-wide significant intronic susceptibility variant in BTBD9 strongly predisposing individuals to restless legs syndrome and periodic limb movements in sleep.
A regulatory intron variant in BTBD9 strongly associated with periodic limb movements in sleep.
Intronic risk variant in BTBD9 strongly associated with periodic limb movement in sleep (PLMS) and restless legs syndrome (RLS).
Common non-coding regulatory variant in BTBD9 influencing restless legs syndrome risk and periodic leg movements during sleep.